, Volume 11, Issue 2, pp 175-178,
Open Access This content is freely available online to anyone, anywhere at any time.
Date: 09 Feb 2010

A pilot study of topiramate dosages for migraine prophylaxis in an Asian population

Abstract

Topiramate is known to be efficacious in migraine prophylaxis, but its optimal dose has not been systematically studied in the Asian population. Here, we show that a fixed low dose of topiramate 25 mg/day is efficacious in migraine prophylaxis and also attest to advantages in terms of medication cost savings and more favourable side effect profile.